The Live Nagpur
  • Nagpur City
  • Nagpur Education
  • Nagpur Sports
  • Business
  • Featured
  • Crime
  • Entertainment & Lifestyle
  • Health & Wellness
  • Nation
  • Politics
  • Trending
  • Vidarbha
  • Obituary

The Live Nagpur


  • Home
  • City
  • Politics
  • Business
  • Education
  • Entertainment
  • Sports
  • Health
  • Crime
  • Forest
  • Featured
  • Vidarbha
Health & Wellness

COVID-19 panel recommends Covishield for emergency use

by TLN Team January 2, 2021
written by TLN Team January 2, 2021
COVID-19 panel recommends Covishield for emergency use

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting emergency use authorisation for the Oxford COVID-19 vaccine ‘Covishield’, being manufactured by Serum Institute of India. As per the information, the recommendation comes with certain conditions, but didn’t elaborate. The Drug Controller General of India will take a final call on whether or not to approve the vaccine for emergency usage authorisation. The Pune-based Serum Institute of India (SII), the world’s largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield vaccine which was developed by scientists at Oxford University. The SEC’s recommendation has come days after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approved the Oxford vaccine produced by AstraZeneca in the UK for human use.

Meanwhile, the daily new coronavirus infections in India remained below 30,000 for the 19th consecutive day, taking the total caseload to 1, 02,86,709. Additionally, the national recovery rate rose to 96.08 percent with the number of patients having recuperated from the disease at 98.83 lakh, according to the Union Health Ministry data updated on Friday. A vaccine distribution dry-run is set to begin in four districts in Maharashtra on Saturday.

State health minister Rajesh Tope on Thursday said four districts in the state have been selected for a dry run of the coronavirus vaccine. Besides Covishield, the SEC is also looking at the EUA application of Pfizer (filed on 4 December) and Hyderabad-based Bharat Biotech, which had sought the nod for its indigenously developed Covaxin on 7 December. The SEC on COVID-19 of the CDSCO, which had earlier sought additional safety and immunogenicity data from SII, deliberated on its application seeking emergency use authorisation (EUA) for the shots on Wednesday and met again on Friday to review the matter. SII had applied to the DCGI for EUA for Oxford COVID-19 vaccine on 6 December.

0 comment
FacebookTwitterLinkedin
TLN Team

previous post
Pench National Park gets First Place among National Parks across Country
next post
COVID-19 vaccines will be provided free to all- Dr Harsh Vardhan

You may also like

Special on the occasion of World Alzheimer’s Day...

September 21, 2023

Heartfulness App is the Only Meditation App Supporting...

September 12, 2023

 Let’s eat and Celebrate:  World Samosa Day

September 5, 2023

Ahar Jagar and Breast Cancer Awareness Program under...

September 4, 2023

Alarming Condition: 3,000 Dengue Suspects in the City

August 30, 2023

Common Mistakes When Buying ULIP Schemes

August 29, 2023

Rule for doctors to prescribe generic drugs put...

August 25, 2023

5 Health Benefits of Ashwagandha

August 23, 2023

Only registered Sonography Centres allowed to operate: CS

August 21, 2023

1245 suspected Dengue patients found in the Last...

August 19, 2023

Trending News

  • 3 Idiots’ actor Akhil Mishra dies at 58, falls off building

    September 21, 2023
  • Adidas launches new jersey of team India for ICC World Cup 2023

    September 20, 2023
  • Asia Cup champions team India arrives in Mumbai in style, Watch Video

    September 18, 2023
  • Ind vs Sri Lanka: Will India end 5-year wait to lift Asia Cup trophy?

    September 17, 2023
  • Aircraft skids off Mumbai airport runway and breaks in 2 parts

    September 14, 2023

Important Links

  • Politics
  • Crime
  • Business
  • Education
  • Entertainment
  • Sports

Available on Playstore & Coming Soon on Appstore

Sign-Up Form

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Footer Logo
  • Nagpur City
  • Nagpur Education
  • Nagpur Sports
  • Business
  • Featured
  • Crime
  • Entertainment & Lifestyle
  • Health & Wellness
  • Nation
  • Politics
  • Trending
  • Vidarbha
  • Obituary
  • Privacy Policy
  • Cookie Policy
  • Terms Of Use
  • Advertise with Us

© 2020 - The Live Nagpur . All Rights Reserved.